Tests
Myeloid Dendritic Cell to Leukocyte Ratio Measurement
The determination of the ratio of the myeloid dendritic cells to leukocytes present in a sample. The measurement may be expressed as a ratio or percentage.
Loading
Loading
Search products, companies, tests, and guides — go from query to quote request in one place.
Tests
The determination of the ratio of the myeloid dendritic cells to leukocytes present in a sample. The measurement may be expressed as a ratio or percentage.
Tests
The determination of the ratio of the type 1 myeloid dendritic cells to leukocytes present in a sample. The measurement may be expressed as a ratio or percentage.
Tests
The determination of the ratio of the type 2 myeloid dendritic cells to leukocytes present in a sample. The measurement may be expressed as a ratio or percentage.
Tests
The determination of the ratio of type 4 myeloid dendritic cells to leukocytes present in a sample. The measurement may be expressed as a ratio or percentage.
Tests
A BCR-ABL1 genetic test uses a sample of blood or bone marrow to look for an abnormal gene called BCR-ABL1. This abnormal gene is found in certain types of blood cancer , such as chronic myeloid leukemia (CML).
Tests
The determination of the amount of CD33 expressing cells per unit present in a sample.
Tests
The determination of the amount of CCL23, chemokine (C-C motif) ligand 23, present in a sample.
Tests
The determination of the ratio of monocytes classic to myeloid cells present in a sample. The measurement may be expressed as a ratio or percentage.
Tests
The determination of the ratio of dendritic cells to myeloid cells present in a sample. The measurement may be expressed as a ratio or percentage.
Tests
The determination of the amount of double-negative myeloid dendritic cells (any myeloid dendritic cell that is both CD1c-CD141-) present in a sample.
Tests
The determination of the number of double-negative myeloid-derived suppressor cells (any MDSC that is both CD14- and CD15-) present in a sample.
Tests
The determination of the ratio of a sub-population of double-negative myeloid-derived suppressor cells to all double-negative myeloid-derived suppressor cells present in a sample. The measurement may be expressed as a ratio or percentage.